Astellas Pharma Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Apr '26 Apr 27, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Capitalization	4,131,181	4,512,563	2,589,390	2,946,773	3,381,409	3,519,738
Market Cap Growth	67.78%	74.27%	-12.13%	-12.85%	-3.93%	11.33%
Enterprise Value	4,417,368	4,985,287	3,324,889	3,565,926	3,003,971	3,170,189
Last Close Price	2306.00	2519.00	1391.08	1508.43	1665.16	1636.75
PE Ratio	14.22	15.48	51.03	172.88	34.26	28.37
Forward PE	12.55	14.08	18.73	21.06	15.87	16.50
PS Ratio	1.93	2.11	1.35	1.84	2.23	2.72
PB Ratio	2.26	2.47	1.71	1.85	2.24	2.41
P/TBV Ratio	10.57	11.54	-	-	5.48	6.59
P/FCF Ratio	8.22	8.98	16.44	21.92	11.61	15.53
P/OCF Ratio	7.37	8.06	13.31	17.09	10.32	13.67
PEG Ratio	0.19	0.23	0.17	1.48	0.68	0.70
EV/Sales Ratio	2.06	2.33	1.74	2.22	1.98	2.45
EV/EBITDA Ratio	7.71	8.68	7.19	12.63	8.90	10.64
EV/EBIT Ratio	11.68	13.12	12.62	28.62	12.97	14.53
EV/FCF Ratio	8.79	9.92	21.11	26.53	10.31	13.98
Debt / Equity Ratio	0.31	0.31	0.62	0.63	0.14	0.15
Debt / EBITDA Ratio	0.98	0.98	2.03	3.57	0.61	0.72
Debt / FCF Ratio	1.13	1.13	5.95	7.50	0.70	0.94
Net Debt / Equity Ratio	0.16	0.16	0.50	0.42	-0.11	-0.07
Net Debt / EBITDA Ratio	0.50	0.50	1.62	2.38	-0.51	-0.34
Net Debt / FCF Ratio	0.57	0.57	4.75	5.00	-0.59	-0.45
Asset Turnover	0.62	0.62	0.55	0.53	0.63	0.56
Inventory Turnover	1.30	1.30	1.28	1.38	1.76	1.60
Quick Ratio	0.86	0.86	0.79	0.69	1.13	1.05
Current Ratio	1.17	1.17	1.13	0.93	1.45	1.34
Return on Equity (ROE)	17.44%	17.44%	3.26%	1.10%	6.65%	8.72%
Return on Assets (ROA)	6.88%	6.88%	4.77%	2.58%	6.05%	5.92%
Return on Invested Capital (ROIC)	13.91%	13.44%	11.63%	4.72%	12.83%	12.80%
Return on Capital Employed (ROCE)	16.20%	16.20%	11.60%	5.50%	13.40%	13.30%
Earnings Yield	7.06%	6.46%	1.96%	0.58%	2.92%	3.52%
FCF Yield	12.16%	11.13%	6.08%	4.56%	8.62%	6.44%
Dividend Yield	3.35%	3.10%	5.32%	4.64%	3.60%	3.06%
Payout Ratio	46.68%	46.68%	254.19%	684.38%	101.66%	68.69%
Buyback Yield / Dilution	0.00%	0.00%	0.14%	1.39%	1.38%	0.41%
Total Shareholder Return	3.16%	3.10%	5.46%	6.03%	4.98%	3.46%

Updated Mar 31, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.